Pratt E, Ma X, Liu R, Robins D, et al. Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes. Diabetes Obes Metab 2023 Jun 1. doi: 10.1111/dom.15150.
PMID: 37264711